SNDX
Price
$16.71
Change
-$0.38 (-2.22%)
Updated
Nov 19 closing price
Capitalization
1.45B
109 days until earnings call
Intraday BUY SELL Signals
WHWK
Price
$2.09
Change
-$0.05 (-2.34%)
Updated
Nov 19 closing price
Capitalization
98.03M
112 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

SNDX vs WHWK

Header iconSNDX vs WHWK Comparison
Open Charts SNDX vs WHWKBanner chart's image
Syndax Pharmaceuticals
Price$16.71
Change-$0.38 (-2.22%)
Volume$1.94M
Capitalization1.45B
Whitehawk Therapeutics
Price$2.09
Change-$0.05 (-2.34%)
Volume$175.52K
Capitalization98.03M
SNDX vs WHWK Comparison Chart in %
SNDX
Daily Signal:
Gain/Loss:
WHWK
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
SNDX vs. WHWK commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNDX is a Hold and WHWK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (SNDX: $16.71 vs. WHWK: $2.08)
Brand notoriety: SNDX and WHWK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SNDX: 66% vs. WHWK: 8%
Market capitalization -- SNDX: $1.45B vs. WHWK: $98.03M
SNDX [@Biotechnology] is valued at $1.45B. WHWK’s [@Biotechnology] market capitalization is $98.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNDX’s FA Score shows that 1 FA rating(s) are green whileWHWK’s FA Score has 0 green FA rating(s).

  • SNDX’s FA Score: 1 green, 4 red.
  • WHWK’s FA Score: 0 green, 5 red.
According to our system of comparison, WHWK is a better buy in the long-term than SNDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNDX’s TA Score shows that 5 TA indicator(s) are bullish while WHWK’s TA Score has 4 bullish TA indicator(s).

  • SNDX’s TA Score: 5 bullish, 5 bearish.
  • WHWK’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, SNDX is a better buy in the short-term than WHWK.

Price Growth

SNDX (@Biotechnology) experienced а -0.48% price change this week, while WHWK (@Biotechnology) price change was -6.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.19%. For the same industry, the average monthly price growth was -5.74%, and the average quarterly price growth was +63.93%.

Reported Earning Dates

SNDX is expected to report earnings on Mar 09, 2026.

WHWK is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (-2.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNDX($1.45B) has a higher market cap than WHWK($98M). SNDX YTD gains are higher at: 26.399 vs. WHWK (-34.073). WHWK has higher annual earnings (EBITDA): -10.21M vs. SNDX (-314.25M). SNDX has more cash in the bank: 469M vs. WHWK (177M). WHWK has less debt than SNDX: WHWK (0) vs SNDX (1.68M). SNDX has higher revenues than WHWK: SNDX (77.9M) vs WHWK (21.6M).
SNDXWHWKSNDX / WHWK
Capitalization1.45B98M1,482%
EBITDA-314.25M-10.21M3,077%
Gain YTD26.399-34.073-77%
P/E RatioN/A11.67-
Revenue77.9M21.6M361%
Total Cash469M177M265%
Total Debt1.68M0-
FUNDAMENTALS RATINGS
SNDX vs WHWK: Fundamental Ratings
SNDX
WHWK
OUTLOOK RATING
1..100
6173
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
58
Fair valued
PROFIT vs RISK RATING
1..100
9597
SMR RATING
1..100
9890
PRICE GROWTH RATING
1..100
4147
P/E GROWTH RATING
1..100
436
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WHWK's Valuation (58) in the Pharmaceuticals Major industry is somewhat better than the same rating for SNDX (91) in the Biotechnology industry. This means that WHWK’s stock grew somewhat faster than SNDX’s over the last 12 months.

SNDX's Profit vs Risk Rating (95) in the Biotechnology industry is in the same range as WHWK (97) in the Pharmaceuticals Major industry. This means that SNDX’s stock grew similarly to WHWK’s over the last 12 months.

WHWK's SMR Rating (90) in the Pharmaceuticals Major industry is in the same range as SNDX (98) in the Biotechnology industry. This means that WHWK’s stock grew similarly to SNDX’s over the last 12 months.

SNDX's Price Growth Rating (41) in the Biotechnology industry is in the same range as WHWK (47) in the Pharmaceuticals Major industry. This means that SNDX’s stock grew similarly to WHWK’s over the last 12 months.

SNDX's P/E Growth Rating (4) in the Biotechnology industry is in the same range as WHWK (36) in the Pharmaceuticals Major industry. This means that SNDX’s stock grew similarly to WHWK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SNDXWHWK
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
89%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 9 days ago
82%
Bullish Trend 8 days ago
78%
Declines
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 13 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
69%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
SNDX
Daily Signal:
Gain/Loss:
WHWK
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGICX51.48N/A
N/A
Hartford Core Equity C
CCTRX12.92N/A
N/A
Columbia Sm Cp Val and Inflection R
GFVSX14.10N/A
N/A
Goldman Sachs Value Opportunities ETF
TNBRX20.40N/A
N/A
1290 SmartBeta Equity R
MGLIX16.28-0.12
-0.73%
MFS Global Real Estate I

SNDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNDX has been loosely correlated with REPL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SNDX jumps, then REPL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNDX
1D Price
Change %
SNDX100%
-2.22%
REPL - SNDX
51%
Loosely correlated
+2.86%
XENE - SNDX
45%
Loosely correlated
+0.15%
VCYT - SNDX
45%
Loosely correlated
+3.02%
ACLX - SNDX
45%
Loosely correlated
-0.38%
IDYA - SNDX
43%
Loosely correlated
-1.72%
More

WHWK and

Correlation & Price change

A.I.dvisor indicates that over the last year, WHWK has been loosely correlated with AXON. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if WHWK jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WHWK
1D Price
Change %
WHWK100%
-2.80%
AXON - WHWK
44%
Loosely correlated
-0.50%
DMAC - WHWK
41%
Loosely correlated
+5.94%
AMRN - WHWK
37%
Loosely correlated
+1.08%
ARRY - WHWK
36%
Loosely correlated
-2.47%
SNDX - WHWK
34%
Loosely correlated
-2.22%
More